Parasitic Worm Consumes Female Reproductive Organs
By LabMedica International staff writers Posted on 16 Nov 2010 |
![Image: Schistosoma haematobium egg (photo courtesy Sinclair Stammers World Health Organization [WHO]). Image: Schistosoma haematobium egg (photo courtesy Sinclair Stammers World Health Organization [WHO]).](https://globetechcdn.com/mobile_labmedica/images/stories/articles/article_images/_LM/20101108 - RLJ145.gif)
Image: Schistosoma haematobium egg (photo courtesy Sinclair Stammers World Health Organization [WHO]).
A parasitic helminth eats its way into the female internal reproductive organs inflicting considerable damage, and making them particularly vulnerable to infection.
The parasitic disease, commonly known as snail fever, or schistosomiasis, which is transmitted via parasites in the water, was until recently thought to cause chronic illness, but damage to the reproductive systems was slight.
A Danish study from Faculty of Life Sciences at the University of Copenhagen (LIFE; Copenhagen, Denmark), shows that what the parasite does is to lay eggs in the reproductive organs, resulting in chronic infection. This infection causes perforations or sores in the woman's uterine tissues. For many of the millions of women who have been repeatedly infected with the parasite, it is not actually possible to do anything once the damage has been done.
The field study, carried out on Madagascar, shows that the parasite also inflicts considerable damage to women's reproductive organs, making them particularly vulnerable to infection. There was a connection between the illness and infertility and though men are also infected, they have fewer symptoms than women do. The scientists revealed that there is an infectious reaction and saw that the infected cells are spread through the man's semen. The prevalence of schistosomiasis on the island is estimated as 2.5 million infected people.
Niels Ørnbjerg, D.Sc., director of Veterinary Disease Biology at LIFE, said, "We know that 200 million people are already infected with the parasite. What we did not know before now was that over the years the parasite causes sores in the woman's reproductive organs, which makes it easier for infections such as HIV to take hold.” Birgitte J. Vennervald, M.D., a senior researcher on the project said, "For many of the millions of women who have been repeatedly infected with the parasite, it is not actually possible to do anything once the damage has been done. However, the prospects look slightly brighter for younger women where the parasite has not yet disappeared from the body."
Early clinical manifestations of schistosomiasis are urticaria, fever and eosinophilia. Later, dysuria, hematuria and obstructive nephropathy or hepatosplenomegaly and portal hypertension may appear. Microscopic identification of eggs in stool or urine is the most practical method for diagnosis. Urinary form is often complicated by bladder cancer in advanced cases, as the parasite may survive for decades in human host. There are recurrent reports of outbreaks among immigrants and travelers who have been in infected water sources in the tropics.
Related Links:
University of Copenhagen
The parasitic disease, commonly known as snail fever, or schistosomiasis, which is transmitted via parasites in the water, was until recently thought to cause chronic illness, but damage to the reproductive systems was slight.
A Danish study from Faculty of Life Sciences at the University of Copenhagen (LIFE; Copenhagen, Denmark), shows that what the parasite does is to lay eggs in the reproductive organs, resulting in chronic infection. This infection causes perforations or sores in the woman's uterine tissues. For many of the millions of women who have been repeatedly infected with the parasite, it is not actually possible to do anything once the damage has been done.
The field study, carried out on Madagascar, shows that the parasite also inflicts considerable damage to women's reproductive organs, making them particularly vulnerable to infection. There was a connection between the illness and infertility and though men are also infected, they have fewer symptoms than women do. The scientists revealed that there is an infectious reaction and saw that the infected cells are spread through the man's semen. The prevalence of schistosomiasis on the island is estimated as 2.5 million infected people.
Niels Ørnbjerg, D.Sc., director of Veterinary Disease Biology at LIFE, said, "We know that 200 million people are already infected with the parasite. What we did not know before now was that over the years the parasite causes sores in the woman's reproductive organs, which makes it easier for infections such as HIV to take hold.” Birgitte J. Vennervald, M.D., a senior researcher on the project said, "For many of the millions of women who have been repeatedly infected with the parasite, it is not actually possible to do anything once the damage has been done. However, the prospects look slightly brighter for younger women where the parasite has not yet disappeared from the body."
Early clinical manifestations of schistosomiasis are urticaria, fever and eosinophilia. Later, dysuria, hematuria and obstructive nephropathy or hepatosplenomegaly and portal hypertension may appear. Microscopic identification of eggs in stool or urine is the most practical method for diagnosis. Urinary form is often complicated by bladder cancer in advanced cases, as the parasite may survive for decades in human host. There are recurrent reports of outbreaks among immigrants and travelers who have been in infected water sources in the tropics.
Related Links:
University of Copenhagen
Latest Microbiology News
- Handheld Device Delivers Low-Cost TB Results in Less Than One Hour
- New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
- Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
- Innovative ID/AST System to Help Diagnose Infectious Diseases and Combat AMR
- Gastrointestinal Panel Delivers Rapid Detection of Five Common Bacterial Pathogens for Outpatient Use
- Rapid PCR Testing in ICU Improves Antibiotic Stewardship
- Unique Genetic Signature Predicts Drug Resistance in Bacteria
- Unique Barcoding System Tracks Pneumonia-Causing Bacteria as They Infect Blood Stream
- Rapid Sepsis Diagnostic Test Demonstrates Improved Patient Care and Cost Savings in Hospital Application
- Rapid Diagnostic System to Detect Neonatal Sepsis Within Hours
- Novel Test to Diagnose Bacterial Pneumonia Directly from Whole Blood
- Interferon-γ Release Assay Effective in Patients with COPD Complicated with Pulmonary Tuberculosis
- New Point of Care Tests to Help Reduce Overuse of Antibiotics
- 30-Minute Sepsis Test Differentiates Bacterial Infections, Viral Infections, and Noninfectious Disease
- CRISPR-TB Blood Test to Enable Early Disease Diagnosis and Public Screening
- Syndromic Panel Provides Fast Answers for Outpatient Diagnosis of Gastrointestinal Conditions
Channels
Clinical Chemistry
view channel
‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection
Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more
Low-Cost Portable Screening Test to Transform Kidney Disease Detection
Millions of individuals suffer from kidney disease, which often remains undiagnosed until it has reached a critical stage. This silent epidemic not only diminishes the quality of life for those affected... Read more
New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma
Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read moreMolecular Diagnostics
view channel
New Genetic Tool Analyzes Umbilical Cord Blood to Predict Future Disease
Children are experiencing metabolic problems at increasingly younger ages, placing them at higher risk for serious health issues later in life. There is a growing need to identify this risk from birth... Read more
Spinal Fluid Biomarker for Parkinson’s Disease Offers Early and Accurate Diagnosis
Parkinson’s disease is a neurodegenerative condition typically diagnosed at an advanced stage based on clinical symptoms, primarily motor disorders. However, by this time, the brain has already undergone... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read morePathology
view channel
Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation
Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more
World’s First AI Model for Thyroid Cancer Diagnosis Achieves Over 90% Accuracy
Thyroid cancer is one of the most common cancers worldwide, and its precise management typically relies on two primary systems: (1) the 8th edition of the American Joint Committee on Cancer (AJCC) or ... Read more
Breakthrough Diagnostic Approach to Significantly Improve TB Detection
Tuberculosis (TB) remains the deadliest infectious disease globally, with 10.8 million new cases and 1.25 million deaths reported in 2023. Early detection through effective screening is crucial in identifying... Read more
Rapid, Ultra-Sensitive, PCR-Free Detection Method Makes Genetic Analysis More Accessible
Genetic testing has been an important method for detecting infectious diseases, diagnosing early-stage cancer, ensuring food safety, and analyzing environmental DNA. For a long time, polymerase chain reaction... Read moreTechnology
view channel
Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. While traditional detection methods are... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more